# HUTCHMED (China) Ltd: Form 20-F for the period ended Dec 31, 2017

- Company: [HUTCHMED (China) Ltd](/companies/hcm.md) (CIK 1648257)
- Form: 20-F
- Filed: 2018-03-12
- Accepted by EDGAR: Mar 12, 2018, 06:25 ET
- Period: 2017-12-31
- Accession: 0001047469-18-001485
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1648257/000104746918001485/a2234463z20-f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1648257/000104746918001485/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2017-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Cost of revenue | 12 months, 2017-01-01 to 2017-12-31 | $169.8m | us-gaap:CostOfGoodsSold |
| Research and development | 12 months, 2017-01-01 to 2017-12-31 | $75.5m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2017-01-01 to 2017-12-31 | −$53.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2017-01-01 to 2017-12-31 | $1.5m | us-gaap:InterestExpense |
| Income tax | 12 months, 2017-01-01 to 2017-12-31 | $3.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2017-01-01 to 2017-12-31 | −$26.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2017-01-01 to 2017-12-31 | −$0.43 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2017-01-01 to 2017-12-31 | −$0.43 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2017-01-01 to 2017-12-31 | 61,717,171 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2017-01-01 to 2017-12-31 | −$8.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2017-01-01 to 2017-12-31 | $5.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months, 2017-01-01 to 2017-12-31 | $1.4m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2017-12-31 | $85.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2017-12-31 | $432.2m | us-gaap:AssetsCurrent |
| Total assets | at 2017-12-31 | $597.9m | us-gaap:Assets |
| Current liabilities | at 2017-12-31 | $104.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2017-12-31 | $113.0m | us-gaap:Liabilities |
| Long-term debt | at 2017-12-31 | $30.0m | us-gaap:LongTermDebt |
| Current portion of debt | at 2017-12-31 | $30.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2017-12-31 | $461.7m | us-gaap:StockholdersEquity |
| Shares outstanding | at 2017-12-31 | 66,447,037 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1648257/000104746918001485/a2234463z20-f.htm

Filed Mar 12, 2018.
Source: SEC EDGAR, the filing index for accession 0001047469-18-001485. Last ingested by Listed: Nov 2, 2026, 06:07 ET. No prices; not investment advice.